Qingdao Haier Biomedical Co., Ltd. (688139) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Qingdao Haier Biomedical Co., Ltd.

Why is Qingdao Haier Biomedical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 12.25% and Operating profit at -9.78% over the last 5 years

With a fall in PBT of -27.97%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 8 consecutive quarters
NET PROFIT(HY) At CNY 86.33 MM has Grown at -49.8%
INTEREST(HY) At CNY 1.89 MM has Grown at 16.3%
ROCE(HY) Lowest at 5.93%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -7.77% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Industrial Manufacturing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Qingdao Haier Biomedical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Qingdao Haier Biomedical Co., Ltd.

-9.72%

-0.77

23.55%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.25%

EBIT Growth (5y)

-9.78%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.36

Sales to Capital Employed (avg)

0.53

Tax Ratio

4.76%

Dividend Payout Ratio

40.52%

Pledged Shares

Institutional Holding

ROCE (avg)

35.57%

ROE (avg)

14.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.38

EV to EBIT

48.99

EV to EBITDA

28.54

EV to Capital Employed

3.24

EV to Sales

3.85

PEG Ratio

Dividend Yield

1.46%

ROCE (Latest)

6.61%

ROE (Latest)

6.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -3.02% (YoY

-21What is not working for the Company

NET PROFIT(HY)

At CNY 86.33 MM has Grown at -49.8%

INTEREST(HY)

At CNY 1.89 MM has Grown at 16.3%

ROCE(HY)

Lowest at 5.93%

DEBT-EQUITY RATIO (HY)

Highest at -27.7 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.85 times

CASH AND EQV(HY)

Lowest at CNY 3,144.94 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.42 times

Here's what is working for Qingdao Haier Biomedical Co., Ltd.

Raw Material Cost

Fallen by -3.02% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Qingdao Haier Biomedical Co., Ltd.

Net Profit

At CNY 86.33 MM has Grown at -49.8%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 1.89 MM has Grown at 16.3%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -27.7 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 4.85 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Cash and Eqv

Lowest at CNY 3,144.94 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 4.42 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio